Customizing Immune Responses to Promote Neuroregeneration
"Sitting on your shoulders is the most complicated object in the known universe." — Michio Kaku
Current Impact
U.S. Economy Loses Total $800B Annually
Over 3 billion people worldwidelive with neurological conditions.
By 2050, the 60+ population will double, further driving neurodegenerative disease risk.
Neuroinflammation Pipeline
We target neuroimmune crosstalk to halt chronic inflammation that drives cognitive decline.
Our approach
Our biologic therapeutics act at the neuroimmune interface, modulating key pathways rather than broadly suppressing immunity, to reprogram immune circuits and promote neuroregeneration.